This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Multicenter Compassionate Use Protocol of Daclat...
Clinical trial

A Multicenter Compassionate Use Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C

Read time: 1 mins
Last updated:25th Mar 2014

The primary objective of this program is to provide Daclatasvir in combination with Sofosbuvir with or without ribavirin to subjects with chronic hepatitis C who are at a high risk of liver decompensation or death within 12 months if left untreated and who have no available therapeutic options.

Category Value
Study start date 2014-03-25

View full details